BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38030082)

  • 1. Spatiotemporally sequential delivery of biomimetic liposomes potentiates glioma chemotherapy.
    Zhou M; Wu Y; Sun M; Qin Y; Zhao J; Qiu Z; Li C; Zhang Y; Xiong Y; Shen Y; Zou Z; Tu J; Shen W; Sun C
    J Control Release; 2024 Jan; 365():876-888. PubMed ID: 38030082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient Anti-Glioma Therapy Through the Brain-Targeted RVG15-Modified Liposomes Loading Paclitaxel-Cholesterol Complex.
    Xin X; Liu W; Zhang ZA; Han Y; Qi LL; Zhang YY; Zhang XT; Duan HX; Chen LQ; Jin MJ; Wang QM; Gao ZG; Huang W
    Int J Nanomedicine; 2021; 16():5755-5776. PubMed ID: 34471351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiopep-2 modified lipid-coated mesoporous silica nanoparticles for glioma targeting therapy overcoming BBB.
    Zhu J; Zhang Y; Chen X; Zhang Y; Zhang K; Zheng H; Wei Y; Zheng H; Zhu J; Wu F; Piao JG; Zhu Z; Li F
    Biochem Biophys Res Commun; 2021 Jan; 534():902-907. PubMed ID: 33162028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. pH-sensitive folic acid and dNP2 peptide dual-modified liposome for enhanced targeted chemotherapy of glioma.
    Li M; Shi K; Tang X; Wei J; Cun X; Chen X; Yu Q; Zhang Z; He Q
    Eur J Pharm Sci; 2018 Nov; 124():240-248. PubMed ID: 30071282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic Combination of Doxorubicin and Paclitaxel Delivered by Blood Brain Barrier and Glioma Cells Dual Targeting Liposomes for Chemotherapy of Brain Glioma.
    Chen X; Yuan M; Zhang Q; Ting Yang Y; Gao H; He Q
    Curr Pharm Biotechnol; 2016; 17(7):636-50. PubMed ID: 27033513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paclitaxel loaded liposomes decorated with a multifunctional tandem peptide for glioma targeting.
    Liu Y; Ran R; Chen J; Kuang Q; Tang J; Mei L; Zhang Q; Gao H; Zhang Z; He Q
    Biomaterials; 2014 Jun; 35(17):4835-47. PubMed ID: 24651033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liposomes actively recognizing the glucose transporter GLUT
    Fu Q; Zhao Y; Yang Z; Yue Q; Xiao W; Chen Y; Yang Y; Guo L; Wu Y
    Arch Pharm (Weinheim); 2019 Feb; 352(2):e1800219. PubMed ID: 30609116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biotin and glucose co-modified multi-targeting liposomes for efficient delivery of chemotherapeutics for the treatment of glioma.
    Liu Q; Zhou L; Lu R; Yang C; Wang S; Hai L; Wu Y
    Bioorg Med Chem; 2021 Jan; 29():115852. PubMed ID: 33189509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Target delivering paclitaxel by ferritin heavy chain nanocages for glioma treatment.
    Liu W; Lin Q; Fu Y; Huang S; Guo C; Li L; Wang L; Zhang Z; Zhang L
    J Control Release; 2020 Jul; 323():191-202. PubMed ID: 31838201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide-22 and Cyclic RGD Functionalized Liposomes for Glioma Targeting Drug Delivery Overcoming BBB and BBTB.
    Chen C; Duan Z; Yuan Y; Li R; Pang L; Liang J; Xu X; Wang J
    ACS Appl Mater Interfaces; 2017 Feb; 9(7):5864-5873. PubMed ID: 28128553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptide-functionalized and high drug loaded novel nanoparticles as dual-targeting drug delivery system for modulated and controlled release of paclitaxel to brain glioma.
    Di Mauro PP; Cascante A; Brugada Vilà P; Gómez-Vallejo V; Llop J; Borrós S
    Int J Pharm; 2018 Dec; 553(1-2):169-185. PubMed ID: 30321641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomimetic Nanocomposites Camouflaged with Hybrid Cell Membranes for Accurate Therapy of Early-Stage Glioma.
    Chi S; Zhang L; Cheng H; Chang Y; Zhao Y; Wang X; Liu Z
    Angew Chem Int Ed Engl; 2023 Jul; 62(29):e202304419. PubMed ID: 37199033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted delivery of nano-PTX to the brain tumor-associated macrophages.
    Zou L; Tao Y; Payne G; Do L; Thomas T; Rodriguez J; Dou H
    Oncotarget; 2017 Jan; 8(4):6564-6578. PubMed ID: 28036254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liposome-based glioma targeted drug delivery enabled by stable peptide ligands.
    Wei X; Gao J; Zhan C; Xie C; Chai Z; Ran D; Ying M; Zheng P; Lu W
    J Control Release; 2015 Nov; 218():13-21. PubMed ID: 26428462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Active targeting of orthotopic glioma using biomimetic liposomes co-loaded elemene and cabazitaxel modified by transferritin.
    Li J; Zeng H; You Y; Wang R; Tan T; Wang W; Yin L; Zeng Z; Zeng Y; Xie T
    J Nanobiotechnology; 2021 Sep; 19(1):289. PubMed ID: 34565383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-delivery of pEGFP-hTRAIL and paclitaxel to brain glioma mediated by an angiopep-conjugated liposome.
    Sun X; Pang Z; Ye H; Qiu B; Guo L; Li J; Ren J; Qian Y; Zhang Q; Chen J; Jiang X
    Biomaterials; 2012 Jan; 33(3):916-24. PubMed ID: 22048008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscone/RI7217 co-modified upward messenger DTX liposomes enhanced permeability of blood-brain barrier and targeting glioma.
    Kang S; Duan W; Zhang S; Chen D; Feng J; Qi N
    Theranostics; 2020; 10(10):4308-4322. PubMed ID: 32292496
    [No Abstract]   [Full Text] [Related]  

  • 18. Berberine and folic acid co-modified pH-sensitive cascade-targeted PTX-liposomes coated with Tween 80 for treating glioma.
    Yang C; Yang Z; Wang S; Chen J; Liu Q; Tianle Huang ; Hai L; Lu R; Wu Y
    Bioorg Med Chem; 2022 Sep; 69():116893. PubMed ID: 35752143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel brain-targeted nanomicelles for anti-glioma therapy mediated by the ApoE-enriched protein corona in vivo.
    Zhang ZA; Xin X; Liu C; Liu YH; Duan HX; Qi LL; Zhang YY; Zhao HM; Chen LQ; Jin MJ; Gao ZG; Huang W
    J Nanobiotechnology; 2021 Dec; 19(1):453. PubMed ID: 34963449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined Biomimetic MOF-RVG15 Nanoformulation Efficient Over BBB for Effective Anti-Glioblastoma in Mice Model.
    Wu H; Liu Y; Chen L; Wang S; Liu C; Zhao H; Jin M; Chang S; Quan X; Cui M; Wan H; Gao Z; Huang W
    Int J Nanomedicine; 2022; 17():6377-6398. PubMed ID: 36545220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.